A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Starting soon · Phase 3 · Has a placebo group

Conditions studied: SARS-CoV-2

In brief

The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized adult and adolescent participants with COVID-19 who are at high risk for progression to severe disease.

Key facts

Study ID
NCT07743580
Run by
Shionogi
People needed
2000
Starts
2026-08-06
Expected to finish
2028-12-31
Last updated by the study team
2026-08-04

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.